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Abstract
Nasal packs are indispensable in ENT practice. This study reviews cur-
rent indications, effectiveness and risks of nasal packs and stents. In
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endoscopic surgery, nasal packs should always have smooth surfaces
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to minimize mucosal damage, improve wound healing and increase
patientcomfort.Functionalendoscopicendonasalsinussurgeryallows Traumatologie, HNO-Klinik,
the use of modern nasal packs, since pressure is no longer required. Städtisches Klinikum
Karlsruhe, Germany So called hemostatic/resorbable materials are a first step in this direc-
tion. However, they may lead to adhesions and foreign body reactions
in mucosal membranes. Simple occlusion is an effective method for
creating a moist milieu for improved wound healing and avoiding dry-
ness. Stenting of the frontal sinus is recommended if surgery fails to
produceawide,physiologicallyshapeddrainagepaththatissufficiently
covered by intact tissue.
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1 Introduction
Nasal packs are indispendable for the ENT practitioner.
Thereisanincreasingnumberofproductsonthemarket
utilizingdifferentmaterials.Thisstudyisdesignedtogive
an overview and represents a revision of the prior publi-
cations by Weber et al. [1] and Beule et al. [2] from the
years 2000 and 2004 respectively. Current literature
from2000to2008hasbeensurveyedtoprovideareview
ofindications,effectivenessandrisksofnasalpacksand
stents. Nasal packs are designed to
• Provide hemostasis after Epistaxis or surgery
• Provide support for the cartilaginous and bony nasal
structure, nasal conchae or soft tissue (i.e. sliding
flaps)
• Prevent adhesions or stenosis, especially following si-
nus surgery. In this case packs should remain placed
for a longer period of time [3], specially formed struts
[3], [4], [5] and certain materials [6] are especially
advantageous.
Thereisnogenerallyrecognizedstandardforwhichtypes
of materials should be used, how longs packs should re-
main placed, or when placement is indicated [1], [2].
Nasal packs
• Apply pressure
• Fill preformed spaces
• Create moist environments to facilitate physiological
processes (i.e. by occlusion)
• Function as a barrier
• Induce physiological hemostatic and reparative pro-
cesses.
Use of nasal packs varies greatly in different countries.
In Germany, for example formed nasal packs
(Formkörpertamponaden = FKT) are usually rubber
covered sponge packs. In the USA merocel PVA-packs
are popular, in England PVA and Telfa packs are used
and in China alginate strips are often used. This diversity
is most likely the result of local market factors and avail-
abilityasmuchasactualdifferencesintheeffectiveness
of the materials themselves. Large comparative studies
are lacking.
Ingeneral,however,thereisatrendtorefrainfromapply-
ing nasal packs whenever possible to increase patient
comfort.
The diversity of materials is great and the following over-
view can not be exhaustive, but should still prove helpful
in giving some general orientation. The following nasal
packs are considered to be relevant nationally and inter-
nationally by the author.
2 Materials for nasal packs
There are two main classesof nasalpacks,formednasal
packs (Chpt 2.1), and the new generation of hemostat-
ic/resorbable/biodegradable packs (HT) (Chpt 2.2).
2.1.1 Rubber coated sponge packs
(Gummifingerlingtamponaden = GFT)
GFTarespongeswithlatexcoveringsthatareimpenetra-
bleforbacteriaandviruses.Differencesinmanufacturing
affect the quality of the latex, the firmness and texture
of thread anchors. If threads are too smooth, the knot
may slip and increase pressure on the columella or alar
cartilage.Forsafetyreasons,“home-made”GFT’sshould
notbeused.Latex-freeGTS’suseaninertsyntheticcover
(Rhinotamp, latex free, Vostra, Aachen) or immerse the
sponge in polyurethane (Schaumstoffnasentamonade
mit latexfreier Behautung, Spiggle & Theis, Overath).
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und and are therefore standard in Germany. They are
easy to place and remove, cause little trauma, bleeding
and discomfort. The pressure applied to the mucosal
membranes can be modified and is usually light to medi-
um.
Two complications warrant further attention:
• Pressurecandamagethenasalvestibulum(columella
and alar cartilage, see Chpt 3.2)
• Posterior dislocation can lead to aspiration (see Chpt
3.3).
2.1.2 Expandable nasal packs (Expandierbare
Nasentamponaden = ENT)
ENT are made of Polyvinyl acetal (PVA) derived from vis-
cose and cellulose (Sugomed).
2.1.2.1 PVA nasal packs (= PVA-NT)
PVA-NTarecompressedandofferedinvariousformsand
sizes. After contact with blood or water, the adhesive
dissolves and the pack expands. The packs can absord
upto20timestheirweightinfluid.Thismakesthepacks
soft and elastic, allowing them to apply light to moderate
pressure in the nasal cavity. Movement of the packs is
determined by the smoothness of the surface and size
of packs. The smaller the pores, the less likely it is for
granulation tissue to grow into the packs and the
smoother the surface. This means that bleeding and
trauma is reduced during placement or removal and pa-
tient comfort is increased. Smaller pores increase the
density of the packs and the maximal tensile strength.
This also leads to slower absorption of liquids and a de-
creaseinthetotalamountofliquidthatcanbeabsorbed.
TheclassicPVA-NTisMerocel.However,thisproduct(and
imitations) has large pores and should therefore not be
used.
Recommended PVA-NT
• have small pores, increasing comfort during removal
(3.08 versus 5 on a VAS 0–10, series 5000) [7].
• arecoated(i.e.MerocelLaminated)andhavecompos-
ite films on the sides, to further minimize tissue
trauma. However, large pores and rough surfaces re-
main on the front and back ends, as well as on top
and on the bottom of the packs.
• are antibacterial (presumed to be effective against E.
coli, Staphylococcus, Yersinia, Serratia and Bacillus
subtilis)
• The best presently available PVA-NT is Netcell (Vostra
GmbH, Aachen) which has the pack wrapped com-
pletelyinasyntheticfilm,whichavoidsallPVAcontact
with tissue (Figure 1). A recent study has confirmed
the usefulness of the complete wrap [8]. In the au-
thor’s opinion, this product, along with the GFT, are
theleasttraumaticFKT’s.Althoughaconfirmingstudy
is lacking, comfort during removal of the Netcell pack
is similar to the removal of a GFT.
Figure 1: Netcell nasal packing
Newer products utilizing Merocel and micro floculated
cellulose (Merocel hemo X, Medtronic) have not been
tested yet.
2.1.2.2 Sugomed
Sugomed is an expandable material available in strips or
plates. It consists of cellulose (31.3%) and viscose
(68.7%) and, expands upon fluid absorption, although
less than PVA-NT. The pores are smaller than classic
Merocel, so pack removal is more comfortable than
Merocel, but still leads to more trauma than smooth
surface packs. The main advantage over Merocel, is the
individualized sizing and shaping of the plates or strips.
One long strip can be placed in both nasal cavities.
However, care should be taken to avoid pressure to the
columella.
2.1.3 Rapid Rhino (see 2.2.5)
Rapid Rhino is a nasal pack with a sponge core (models
include Riemann, Goodman or Mannheim in different
lengths) or a balloon covered by carboxymthylcellulose
(CMC). CMC covers both effective agents, the balloon
catheter and the sponge core, which apply pressure and
fill space in the nasal cavity, making the pack an FKT by
definition. Even if CMC induces aggregation of thrombo-
cytesandthushemostasis,thiseffectmostlikelycontrib-
utes little to the overall effect. Upon contact with water
(notsaline)agelisproducedthatmakesthesurfacevery
smooth and supports healing of the nasal membranes.
Thismaybeimportantforthespongecorepack,butmost
likely contributes little to the overall effect of the balloon
catheter pack. Nylon threads are stitched into the packs
may get caught in the nasal cavity and impair removal.
Gel formation, which helps produce occlusive wound
healing and supports physiological hemostasis can be
achievedusingpureCMCintheSinu-KitorStammberger
gel (see 2.2.5).
As expected, Rapid Rhino showed better performance
than PVA-NT in terms of patient comfort (pain during
placement and removal, epistaxis) [9], [10]. Effectivity
for use on patients with epistaxis or after sinus surgery
wasjudgedtobefavorable[9],[10],[11],[12].Theauthor
feels that the sponge core model is comparable to GFT
(Rhinotamp Latexrei, Vostra, Aachen) but easier to com-
press, which makes placement easier and reduces the
risk of pressure necrosis. The risk of dislocation is lower
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catheter model was not judged favorably (see 2.1.5).
2.1.4 Cotton gauze strips
(Baumwollgazestreifen = BWGS)
BWGS differ in width of strips, size of knitting structure
and the threads attached. They can be used alone or
saturated in medicine. Usually vaseline or antibiotic
ointmentsareused.Ointmentshelpmakethestripsglide
intothenoseandpreventcrusting.Antibioticsarethought
to prevent infections, but this has not yet been demon-
strated. Because of the low effectivity, BWGS should not
be used after operations on the nasal septum, the
conchae or sinuses. The author considers the use of
BWGS’s for epistaxis or repositioning of nasal fractures
possible. However, even in these cases, better alterna-
tives seem available. Although often practiced, BWGS’s
shouldnotbeusedaftersinussurgery.Thisisrecommend-
ed for medicolegal reasons. BWGS’s can cause pressure
necrosis, epistaxis upon removal, paraffine granulomas,
discomfort during placement and removal, discouraging
their use.
2.1.5 Balloon packs/balloon catheter
(Ballonkatheter = BK)
Perhapstheonlyindicationisseriousposteriorepistaxis,
whichcanbecontrolledquicklyandeffectivelyusingBK’s.
BK’s do not apply pressure directly to branches of the
sphenopalatineartery, but can sealoff the nasopharynx.
If occlusion is achieved in the anterior nasal cavity,
pressure may be built up indirectly and lead to compres-
sion of bleeding vessels. Simple BK’s have one balloon
(nasopharynx).SomeBK’sareequipedwithtwoballoons
(nasal cavity and nasopharynx). The author has the fol-
lowingreservationsagainsttheuseofcatheterswithtwo
balloons:
• Thehighpressurebuiltupintheanteriorballoondoes
notleadtodirectcompressionofbleedingvesselsand
is applied directly to the nasal septum and turbinates
and can lead to necrosis. The nasal septum is dis-
lodged to the other side [13]. If the anterior balloon
does lead to direct compression of a bleeding vessel,
thentheauthorassumesthebleedingcanbemanaged
by cautery or less invasive packs.
• The nasal end of the pack can cause damage to the
nasal vestibulum, especially if the catheter is not of
sufficientlength.Thereforelongerpacksshouldalways
be used.
Thusdouble-ballooncathetersofsufficientlengthcanbe
used,however,onlytheposteriorballoonshouldbefilled.
Theanteriorballoonshouldbeleftemptyandanaddition-
al NT applied.
Arthrocare also provides a new variant with Rapid Rhino
120. The two balloon chambers are connected to each
other and are filled together. The author sees no benefit,
however, since the balloon still applies pressure in the
nasal cavity. The CMC cover can not hide the fact that a
BK is being used and is the effective agent. The author
also does not recommend using Rapid Rhino of 5 cm or
7 cm length with balloon, since they also apply high
pressure to the nasal cavity and less invasive products
are available. In the author’s experience heavy bleeding
fromthesphenopalatinearteryisnotcontrolledwellwith
BK’sandshouldbeclippedorcauterizedendoscopically.
The following should be considered:
• Sinsussurgeryassuchisusuallynotrequired,butmay
be necessary to identify the posterior wall of the max-
illary sinus
• Multiple branches may be present [14]
• According to Simmen (personal communication), the
branch leading to the anterior wall of the sphenoid si-
nus is most often affected.
Although commercially available BK’s are more sophisti-
cated, simple Foley catheters are more cost efficient. A
problem common to all BK’s is the difficulty of securing
the catheters. A number of recommendationshave been
made to limit necrosis of the nasal ala:
• Anterior nasal pack with sturdy knot [15]
• Foam coating [16]
• The distal end is cut off and placed 8 cm beyond the
proximal end of the dilated balloon and secured with
a clamp [17]
Foley catheters should be filled with water, not air, since
both latex and silicone catheters leak the air within 24
hours. Latex catheters can leak saline as well [18]. Par-
affincandamagetherubber,soparaffinointmentsshould
not be used with Foley catheters [19].
2.1.6 Alginate
Alginate (i.e. Sorbalgon) is made from sea algae. It is a
polysacharide similar to cellulose and produces a gel
upon contact with water. In wounds, alginate absorbs
high sodium exudate and discharges calcium ions to
produce soluble sodium-alginate. This produces a moist
gelfilmonthewoundsurface.Thecalciumionsstimulate
physiolgical clotting. The gel that is produced is hydro-
phile, binds fluid, encases bacteria and cell debris and
thus supports wound cleansing. Alginate can bind up to
20 times its weight in fluid. The moist micro-climate also
supports granulation and epithelial regeneration.
In 1989 and 1992 Sirimanna first compared GFT’s and
gauze packs with alginate after surgery of the conchae
and found alginate to be less traumatic [1]. In a current
randomized clinical study of 50 patients, alginate was
comparedtoMerocelafterconchotomy.Followingremoval
(after 2 days), alginate showed less bleeding and was
found to be less painful (2.53 versus 5.6 on a VAS of
0–10)[20].InChinaalginateiswidelyusedandisjudged
favorably. A number of reports support this observation,
including a number of studies published in Chinese. Algi-
nate is applied as a braided strip, left for a one day and
stops epistaxis reliably. In personal communication to
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areverysensitiveaboutbloodysecretionsfollowingnasal
surgery. If the pack is left in place longer, removal be-
comes difficult because of the gel production and frag-
mentation of the alginate strips. Based on their use in
China, alginates can be classified as an FKT. If left in the
nasal cavity longer than one day, they may be classified
as HT. The main benefit in using alginate is the gel pro-
duction, which leads to higher patient comfort and the
hemostaticproperties.Themaindisadvantageispossible
developmentofgranulationwhichcanleadtoadhesions.
The author sees no reason at present to use alginate.
2.1.7 Telfa
Telfa is a surgical wound dressing made of cotton fibres
enclosed in a sleeve of polyethylene terefphthalate that
is perforated in a regular pattern, designed to prevent
granulation. Telfa is used in Great Britain. The author
sees no need to introduce the product in Germany at
present.
2.1.8 Cellulose-Tabotamp
Tabotampconsistsofoxidizedregeneratedcelluloseand
is used for hemostasis in deeper regions of the nasal si-
nuses that are difficult to access (i.e. sphenoid sinus,
cavernoussinus)andthusdifficulttomanagebyclipping
orcauteryorforfixationofdurareconstructions.Incases
of diffuse bleeding, a thin layer may be sufficient to sup-
port physiological hemostasis. Otherwise, hemostasis is
achieved by pressure. In this case it is important to avoid
secondary damage to sensitive structures (posterior
ethmoid, sphenoid sinus, skull base) by applying only
moderate and avoiding excessive pressure. Tabotamp
createsanacidicenvironmentwithapHofabout3,which
helps avoid infections. However, Tabotamp can lead to
granulation, causing adhesions or stenosis, especially in
thefrontalandethmoidsinuses.“Resorbtion”oftentakes
many weeks, since the materials are not actually hydro-
lysed and reabsorbed. Instead, small particles are trans-
ported, suctioned, incorporated in granulations or de-
graded in air. According to the manufacturer, what hap-
pens to tabotamp after application in the nasal sinuses
has not been systematically analysed.
2.2
Hemostatic/resorbable/biodegradable
packs (Hämostatische Tamponaden =
HT)
Patientsexpectationsofcomfortaftersinussurgeryhave
increased. Considering the risks of nasal packs (see
Chapter 3), some have abandonednasal packs altogeth-
er, leading to the development of new products, that do
not have the same properties (pressure and support) as
formed packs. Conventional nasal packs have disadvan-
tages:
• Thepresureofthepackandtraumaduringapplication
or removal can lead to cilial damage (Chapter 3.2)
• Removal can lead to trauma and bleeding (Chapter
3.2)
• The pressure caused by packing is uncomfortable
(Chapter 3.1)
• Nasal packs have further specific risks (see Chapter
3.2 – 3.11)
In nasal septum surgery, nasal packs can be avoided if
certainsuturetechniquesandsplintsareused.Inmodern
conchal and sinus surgery (FESS), nasal packs are often
not required. In contrast, agressive conchal reduction or
radical sinus surgery often lead to profuse bleeding that
requires formed packs since only these apply sufficient
pressure. Using more gentle endoscopic sinus surgical
techniques leads not only to comparable or superior
surgical results, but also reduces disadvantages like
crusting, scarring or osteogenesis following trauma. Fi-
nally, more comfortable nasal packs can be used.
In a series of 165 patients, Orlandi and Lanza were able
toshowthatonly11.2%ofpatientsundergoingendoscop-
ic sinus surgery required a nasal pack (Kennedy Si-
nuspack).2.4%receivedFloSealandin87%nopackwas
required at all [21]. In a similar study, Elia Schar et al.
showed that 92% of 97 patients did not require a nasal
pack or hemostatic materials [22].
HTaredesignedtoavoidthedisadvantagesofFKT.When
applied only to the wound surfaces in the ethmoid and
possiblyintheentrancetofurthersinuses,theyallowthe
patienttobreathenormally,whichsignificantlyincreases
patientcomfort.Thematerialsdisappearduetoanumber
ofeffectsthataredifficulttoquantify:dissolution,suction,
drainage etc. Different combinations of materials may
lead to different effects:
• Hemostasis
• Placement of tissue through adhesive qualities
• Barrier function
• Improved wound healing
• Sealing surfaces or spaces
A number of materials have been used in the sinuses,
the most important of which will be characterized. All
materials are applied to the middle nasal space, the
ethmoidorpossiblythefrontalrecess.Theyproducegels,
either upon contact with moisture in the nose, or after
preparationbeforeplacement.Insomecases,athinlayer
of gel is applied beforehand.
2.2.1 Gelatine (Gelfilm, Gelfoam)
American authors have described applying gelatine de-
rived from pig skin into the osteomeatal unit or ethmoid
after sinus surgery. This has been done in addition to
nasal pack placement. Application in the sinuses led to
increased scarring, adhesions and shrinkage of the
maxillary meatus [23], [24], [25].
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Flosealisahighlyviscousgelwithhemostaticproperties.
It adheres to irregular and moist surfaces like the nasal
sinuses, even in cases of profuse bleeding [26], and can
be used in patients with reduced thrombocyte counts or
deffective thrombocyte function. Floseal is considered
the most effective HT [6], [27]. However, it also has ad-
verse side effects:
• Increasedscarringandadhesions[28],[29],[30],[31],
[32]
• Foreignbodyreactionsandincorporationinthemuco-
salmembranes,insomeinstancesevenafterapplica-
tion to healthy mucosa (see Chpt. 3.3) [31], [32]
The latest Studies also confirm that HT not only induce
hemostasis, but also have pro-inflammatory properties,
cause granulation, adhesions and scarring [6], [32]. In
the retrospective study by Shrime et al., patients treated
with Floseal were more likely to undergo revision surgery
(25% versus 5.1%) [30].
Another potential disadvantage is the fact that it is a
bovine thrombin-gelatine derivate and thus potentially
transers BSE, although to date no case of infection has
beenreported.AccordingtoBaumann,apporximately80
cases of immunologically mediated blood clotting dis-
orders have been observed, following 180 million appli-
cations [26]. Another factor to consider is the high cost.
2.2.3 Hyaluronic acid (i.e. Merogel, esterified
hyaluronic acid, Sepragel (crosslinked
hyaluronic acid polymers), Seprapack (CMC
combined with hyaluronic acid)
Hyaluronic acid is a natural linear polysacharide (glyco-
amino-glycane) made of repetetive disacharide units of
sodium-d-glucuronate and N-acetyl-d-glucosamine, and
isfoundinthebasalmembranesofcellsandsofttissues.
Itisimportantforcellproliferationandmigration.HAalso
plays an important role in fetal wound healing, which oc-
curs almost without scarring.
In an early study on HA (supragel) used on 10 patients,
the authors described significant improvement in adhe-
sions and stenosis in the middle nasal space in the 2
nd
and 5
th week after surgery [33]. McIntosh et al. found
improvement in re-epithelialisation and cilial repair in
sheep noses (normal mucous membranes without
chronic sinusitis) when using Merogel as compared to
using no nasal pack [34]. In a later study this effect was
no longer observed, when applied to sheep with induced
sinusitis[35].Thisstudydiscussesthecontroversialdata
on effects of Merogel on wound healing in human and
animal studies. In 2 comparable, randomized, blinded,
prospective studies (42+37 patients), no significant dif-
ference between the Merogel and control group was ob-
served following FESS [36], [37].
Study groups around Orlandi have noted that small
changes in the chemical composition of HA lead to signi-
ficant changes in their biomechanical and biological ef-
fects [38], [39]. Proctor also showed increased fibrosis
and foreign body reactions when esterified HA (Merogel)
was used on a 4 mm rabbit maxillary ostium. Other HA
modifications showed no changes in effects [40].
2.2.4 CMC
CMC can be applied as CMC-gel (Stammberger-Gel) or
as moistened Sinu knit strips. Leunig et. al. compared
CMC-gel or Sinu knit with no nasal packs after FESS in a
prospective study. There were no differences in
• Patient comfort (nasal obstruction, head ache, pres-
sure, sleep disorders, general comfort) [41].
• Wound healing after endoscopic nasal sinus surgery
(crusting,adhesions,granulation,woundclosure)[42].
• Hemostasis or postoperative bleeding [43].
Thus, while negative effects were not observed, there
were also no observable advantages to using CMC as
opposed to not using a nasal pack at all.
2.2.5 Other HT
Fibrin glue has been used for epistaxis, M. Osler, clotting
disorders, nasal septumplasty and sinus surgery [44].
Fibrin glue leads to less swelling, crusting and atrophic
scarring, compared to electro coagulation, silver nitrate
or nasal packs in treating epistaxis. An appraisal of the
effects for sinus surgery is not currently possible.
The concept of using physiological growth factors to im-
prove wound healing led to the development of platelete
gel.Thisisgleanedfromplasmaenrichedwithautologous
thrombocytes by centrifuging erythrocytes out of blood.
The remaining sediment has a high concentration of
thrombocytes and physiological fibrin, as well as growth
factors like PDGF (Platelet Derived Growth Factor) and
TGF (Transforming Growth Factor).
Platelet-gel is used in a number of different surgical
specialties. Use in the sinuses was first described by
Kerner 2001 and later by Pomerantz and Dutton 2005
[45]. The latter instilled 8 ml of gel in the sinuses at end
of the surgery. These first studies showed no significant
differencesbetweenMerocelandplatelet-gel,apartfrom
aslightincreaseinqualityoflifeinthePlatelet-gelgroup.
Production of platelet-gel is complex and takes about 30
minutes,requiringacentrifugeandpossiblyextraperson-
nel. Routine use in sinus surgery does not seem justified
intheauthor’sopinion,sincethecost-effectivenessratio
seems unfavourable.
Retinoic acid: Vitamin A and its metabolites play an im-
portant role in the regulation of cell proliferation in the
neuro-sensory and airway systems. Mucocilial and
secretory dysfunction may result from lack of vitamin A.
According to a study by Hwang, application of 00.01%
retinoic acid improved ciliogenesis after sinus surgery,
as observed 14 days post-op [46].
Chondroitin sulfate is a natural, linear polysacharride. It
isoneofseveralextracellularmatrixglycosaminoglycanes,
and has been shown to improved wound healing of skin
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lesions when compared to HA and a control group. In a
study on rabbit maxillary sinuses chondroitin sulfate gel
wasappliedandledtoquickerhealing(ofsmallsurfaces)
after 4 days, but not after 6, 10 and 14 days, since the
edges of the wounds could no longer be identified [47].
Nasopore is a biodegradable polyurethane foam that is
made by dry-freezing. According to the maufacturer, the
product becomes fragmented in 4–6 days. A study of 30
patients posted on the home page of Poliganics showed
Nasopore easy to place and led to healing comparable
to the control group. Adverse side effects were not ob-
served. The datais not sufficientto allow an assessment
and the author has no personal experience with the
product. The video shows application of the product with
an undefined gel. This should be avoided.
2.2.6 Concluding assessment of HT
Chandra and Kern came to the following conclusion in
their review of studies until 2004 [48] (Table 1):
It is currently (2004!) unclear, whether the use of HT in
FESS and postoperative care has any advantages. It is
unclear, whether the necessity of postoperative care is
reduced, when HT are used. They may be useful in
achieving hemostasis and may lead to increased post-
operative patient comfort for patients requiring stents or
placeholders, who do not tolerate conventional NT’s. In
a review by Weitzel and Wormald in 2008, all English
language studies on the use of absorbable materials in
nasal surgery were surveyed and 38 studies evaluated
[6].FloSealwasfoundtobethemosteffectivehemostat-
ic,led,howevertogranulationandadhesions.Toprevent
adhesions, FKT are not more effective than HT and HT
not more effective than no NT. The effects of Mitomycin
C,hyaluronicacidandretinoicacidonscarringandadhe-
sionsinchronicallyinflamedsinuseshasyettobedeterm-
ined. There seem to be indications that this may be the
case, but clear evidence is still lacking. HT can hinder
wound closure, however, by increasing granulation and
adhesions (see above) [49].
Since HT have not yet been shown to improve wound
healing or reduce adhesions (in fact the opposite seems
to be the case, leading even to foreign body reactions –
see Chapter 3.3) the author does not recommend their
use in routine sinus surgery. Considering the high costs,
use can only be justified, if considerable advantages are
expected. Improved nasal breathing can be achieved by
gentle surgical techniques (FESS) or by selective and
short application of NT in the ethmoid (GFT, laminated
PVA, slender Rapid Rhino) in cases of strong bleeding. It
is at present unclear if certain HT materials (i.e. cross-
linked) lead to better results.
2.2.7 New developments – NT, wound healing
and scarring
Scarringandadhesionsaredeterminedbyanequilibrium
between fibrin production and fibrinolysis. If the sinus
ostia remain blocked by blood and fibrin, fibroblasts my
dominate in the proliferative phase of wound healing,
producing fibrin nets. If fibrinolysis is not sufficient,
granulation occurs and finally collagen is deposited. Re-
modelling of collagen in the third post operative week
leads to scarring on concave surfaces. Circular openings
can become concentrically constricted. This process can
continue, with decreasing activity, for months or years.
Scarring can develop out of fibrin and blood deposits,
even if FKT’s are used in the ethmoid, i.e. the SHD.
40 years of research have provided conclusive evidence
that wound healing in a moist environment is better than
inadryenvironment[3].Epithelialregenerationisfaster,
granulation,scarringandpainarereducedandinfections
are less common. Superficial necrosis due to dryness is
avoided. Althoughat presentnot yet completely success-
ful, NT’s aim to achieve the following goals:
• Avoid further traumatization during placement or re-
moval, which can lead to inflammation, irritation, tox-
icity and foreign body reactions by utilizing atraumatic
NT’s or avoiding them altogether
• Occlusionofthenasalcavitytocreateamoistenviron-
ment for wound surfaces
• Increase physiological wound healing processes (epi-
thelial regeneration, restoration of cilial activity) and
inhibition of adverse effects (granulation or scarring)
• Reduce stenosis with scar tissue by acting as a
placeholder or minimizing fibrogenisis
Wound healing can be influenced by surgical technique
as well. Adhesions can be caused by the following:
• Damage to blood vessels or ischemia by coagulation,
pinching tissue or ligations
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debris)
• Blood or bacteria
• Tissue damage by heat and
• Dryness
Therefore surgery should aim to be atraumatic, avoid
excessive dryness or ischemia and avoid contact with
certain materials [50], [51], [52]. Inflammation (either
pre-existingordeveloping)isalsoanimportantfactor[6].
Ontheotherhand,woundhealingcanalsobeinfluenced
pharmacologically. Once it had been observed that HT
not only improve hemostasis, but also lead to scarring,
alternative substances were investigated, that can pre-
vent scarring.
InaCochranereviewthecurrentevidenceforsubstances
preventingorlimitingadhesionsinabdominalandgynae-
cologicalsurgery(>80%adhesionspostop)wassurveyed
[53]. Hyaluronic acid was the only substance which
seemedtoreducetheincidenceofadhesions(oddsratio
0.31; 95% confidence interval 0.19–0.51). However, the
authors considerthe evidenceat presentto be tentative,
consideringthelownumberofcasesdescribed.2studies
describe a reduction in adhesions in second-look laparo-
scopies after application of dextran. The authors come
to the conclusion, however that the evidence for cortisol,
icodextrin (alpha-1,4-glucose polymer), dextran or gel
sprays is not sufficient. 3 substances currently used in
surgicalspecialtiestoreduceadhesionsorachievehemo-
stasis have recently been tested in sinus surgery. First
reportshavebeenmade,butafinalappraisalispending.
Gel spray
Syntheticpolyethylenegelsprayhasbeenusedinsurgery
for a number of years. It is made of two components that
polymerise within seconds of application, forming a
biocompatible, absorbable flexible hydro-gel barrier that
lasts for 5–7 days and is intended to prevent scarring.
The gel is hydrolysed to polyethylene-glycol molecules
that are absorbed for renal elimination. It is considered
non-toxic, bio-degradable, inert synthetic product and
shows no risk of allergic reactions or infection. In a Co-
chrane review in 2006, the evidence for the efficacy of
gel sprays in preventing adhesions was not considered
adequate [53]. In a current randomised study, spray gel
was reported to lead to less peristomal abdominal adhe-
sions [54]. For application during sinus surgery, see
chitosan.
Chitosan
Chitosan is a bio-degradable, non-toxic complex carbo-
hydratederivedfromchitin(poly-β-1-4-N-acetyl-D-clucosa-
min),anaturalpolysaccharidethatresembleshyaluronic
acid and therefore presumably shows similar effects.
Chitosanisthede-acetylised(atleast70%)formofchitin.
If de-acetylisation is 20% or less, the polysaccharide is
termed chitin. Chitosan is derived from shell fish and
squid chitin and shows hemostatic effects, limits adhe-
sionsandisconsideredanti-fungalaswellasanti-bacteri-
al. Chitosan-PVP (polyvinylpyrrolidon hydrogel) limits
growth of fibroblasts by preventing adherence [49], [55],
[56],[57],[58],[59].Epithelialcellgrowthisnotimpaired.
In an animal experiment, 3 substances were tested on a
sheepwithchronicsinusitis:spraygel,recombinedtissue
factor (RFT) (considered to be the prime cellular factor
forinitiatingthecoagulationcascade)andacombination
of 4% dextran and chitosan (CD-gel) [49]. CD-gel led to a
significant reduction of adhesions compared to RFT. RFT
impaired wound healing. Adhesions in the ethmoid were
observed in 40% in the control group, 0% in the CD-gel
group, 14% in the gel spray group and 50% in the RFT
group. Adhesions in the lateral nasal wall were observed
in 15% in the control group, 10% in the CD-gel group,
10% in the gel spray group and 25% in the RFT group.
Epithelial regeneration was significantly better using CD-
gel and gel spray, compared to RFT. First results with
chitosan are promising and encourage further studies.
Microporous polysaccharide hemispheres (= MPH)
MPH is a bio-degradable substance derived from potato
starch and is produced in spheres ranging from 10 to
200 µm. The porous surface absorbes water and small
molecules and thus can concentrate thrombocytes and
coagulationfactors,intensifyingandspeedinghemostasis
[60]. Conglomerations are enzymatically degraded into
solubleproducts.ApplicationofMPHonwoundsinrabbit
maxillary sinuses showed macroscopic and histological
results comparable to the control group, without signs of
increased fibrosis or foreign body reactions [32]. MPH
are promising substances that warrant further investiga-
tion.
2.2.8 Important notice
In the author’s opinion, many studies, including high
quality studies show a methodical flaw that carries over
into assessments and review articles.
The control for the tested substances is often no nasal
pack or Merocel as standard nasal pack. However, the
absence of a nasal pack leads to dryness and slows
wound healing. Superficial necrosis is considered a risk
factor for the development of adhesions and scarring. A
dry milieu leads to considerably worse healing than a
moistmilieu[3],forexamplesimpleocclusionofthenose.
As described above, Merocel must be considered sub
optimal and should not be used. Large pores lead to
granulations and increased adhesions. Therefore, the
conclusionthatMeroceldoesnotinfluencewoundhealing
(either positively or negatively) [61] is not correct, since
“no nasal pack” leads to dryness and impaired wound
healing. It would therefore be desirable and necessary
to see studies compare new materials to favourable
nasalpacks(i.e.GFT,coatedPVA-NT)orsimpleocclusion.
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complications
Risks must be carefully weighed against benefits when
using NT’s. Morbity caused by the general application of
NT’saswellasspecificriskscommontocertainmaterials
should be considered. Is the NT necessary? Can it be re-
placed by materials with less risks and greater patient
comfort? The author has developed an information and
education form which can be downloaded at http://
www.rainerweber.de/(Nasentamponaden/Wundheilung).
3.1 Patient comfort/discomfort
Patient comfort plays an increasingly important role and
must be considered when choosing an NT, even if func-
tionaleffectivityremainstheprimaryconcern.Aprospect-
ivestudybytheauthorshowedthatdetailedexplanations
aboutthenecessityofNT’sincreasepatient’sacceptance.
Even if the NT was required for longer periods of time,
the discomfort experienced by the patients did not in-
crease. Instead, patients showed increased tolerance
[62]. While this requires intensive personal contact on
the part of the physician, it allows occlusion treatments
to be performed for several weeks. Muluk et al. came to
the same conclusion using a fear and depression scale.
Patients showed no significant impairment if they were
sufficiently informed about the surgical procedure and
postoperative NT’s beforehand [63].
Discomfort is mainly caused by
• pain (see above)
• reduction in nasal air flow
• impairedsenseofsmellandincreasednasalsecretion.
Painis mainlycausedby placementandremovalofNT’s,
but may also develop while placed. Removal of NT’s is
oftenrememberedasthemostuncomfortablepartofthe
surgical procedure. Sudies have shown that NT’s with
smooth and fine pore surfaces, that is those with the
leastadhesiontotissue,causetheleastdiscomfortduring
removal. BWG’s cause the most discomfort, followed by
PVA (non-coated) and finally the rest of NT’s. There is no
clear order for GFT, Rapid Rhino or coated PVA. Most
studiesinvestigatingcomfortduringremovalofNT’sfocus
onMerocelwithlargeporesanddescribemoisteningthe
pack before removal, applicatin of local anesthetics or
use of pain medications. The author recommends not
using these types (non-coated PVA-NT) at all. Reduced
nasal air flow can be alleviated by avoiding nasal packs
that fill the nasal space completely or using breathing
straws. While impaired sense of smell and increased
nasal secretion may be caused by nasal packs, they are
also temporarily caused by wound healing.
3.2 Tissue damage – pressure necrosis
Endonasal tissue damage occurs through pressure by
nasal packs or during placement and removal. While su-
perficial tissue damage generally heals well, it may also
leadtothedevelopmentofgranulationsthatbleedeasily
(pyogenic granuloma).These are most often found in the
anteriorsegmentofthenasalseptum.Excessivepressure
over time can lead to necrosis of the mucous tissues,
septal cartilage, and bone in septum or nasal conchae.
Balloon catheters are especially susceptible to pressure
damage, since the pressure is difficult to judge [64].
Other NT’s can also lead to high pressure when applied
in multiple numbers. In a study by Shaw et al. pressure
damage was investigated after 10 minutes [65]. After
application of gauze packs intact ciliated epithelium was
foundin32.3%,afteruseofneurologicalcottonin50.4%
and in the control group in 85%. There was no significant
differencebetweengauze-stripsandneurologicalcotton.
Necrosis of the colummella or alar cartilage can be
caused by threads being too tightly knotted or by the
packsthemselves,especiallywhenballooncathetersare
used. In treating difficult cases of epistaxis, care is not
always taken to assess the length of extra-nasalportions
ofthenasalpack.Pointsofincreasedpressurecancause
problems for the thin epithelium in the nasal vestibulum
orforthecartilage,whichlacksitsownbloodsupply.Thus
even materials which initially seem soft can lead to
ishemia and pressure damage.
It is important to ensure that the threads used to secure
the nasal packs have enough wiggle room. Both the knot
and the anteriorly secured threads should not cut into
thecolumella.Itisimportanttorememberthatswallowing
can cause negative pressure in the post-nasal space,
which may lead to movement of smooth packs. Pressure
damage can be avoided by:
• using threads of sufficient length
• using a guard for the columella
• checking for signs of tissue damage daily.
Pressure damage does not always lead to pain, so pa-
tients may not always notice this complication them-
selves. Damage can lead to lasting scars that may even
require revision surgery. Correct placement of all FKT
must be monitored regularly.
3.3 Foreign body reactions
Jacob et al. were the first to describe neoosteogenesis
in denuded mouse bone in the nasal sinuses after appli-
cation of Merogel [66]. Maccabee et al. described strong
fibrosis of the basal lamina and the propria lamina, loss
of superficial epithelium as well as incorporation of
Merogel in rabbit maxillary sinuses [31]. Resorption of
Merogel was minimal. FloSeal showed similar fibrosis
and loss of mucocilial layers as well as incorporation into
the regenerating membrances. The studies have been
criticized for the application of large amounts of Merogel
ondenudedbones,whichdoesnotreflectclinicalpractice
[37].Wormald’sgroupfoundnosignsofneoosteogenesis
in their studies.
However, current studies by Proctor [40] support the
results of Jacoby and Maccabee. The side effects of
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that the type of HA used (esterified, cross-linked) has a
major effect on mucosa reactions [38].
3.4 Dislocation
Posterior dislocation of nasal packs is the most dreaded
complication. Dislocation can occur regardless of the
material used, as long as form and size allow passage of
thechoanaeintothenasopharynx.GFTandBWG’sseem
especially prone to dislocation. Dislocation results in
gagging and even obstruction of the laryx or trachea.
Cases of lethal asphyxiation have been described and
are presumably due to inadequate securing of packs [1].
Itisimportanttorecognizesymptomsofdisclocationand
react immediately. If in doubt, the nasal pack should al-
waysberemoved.Ifnasalpacksshowsignsofmovement,
gagging and swallowing usually lead to increased
loosening. Therefore the author recommends that prob-
lems with nasal packs be treated immediately as an
emergency. When placing multiple GFT’s it is important
to avoid posterior dislocation of the first pack by the
secondorthirdpacks.Properpositioningcanbechecked
by comparingthreadlength.The assistentshouldsecure
the first pack while the second pack is being placed.
Correct securing of nasal packs (preventing aspiration)
is of first importance and seems, in the author’s opinion,
often to be underestimated. The knot should be placed
in front of the columella and the threads secured by two
strips of adhesive tape. Multiple packs can be knoted
together.
RapidRhino 7.5 cm packs can also be dislocated. In one
case this led to intestinal perforation. The pack was re-
moved by laparotomy [67].
Improperplacementofnasalpackscanevenleadtointra-
cranial displacement, as reported for Foley-catheters,
choanal stents and frontal sinus stents. Nasal packs
shouldthereforealwaysbecheckedforproperplacement.
3.5Obstructive sleepapnoeasyndrome
(OSAS)
Although literature is abundant, there is little agreement
on the effects of nasal packs on sleep related breathing
disorders or oxygen saturation. Induction or worsening
of obstructive sleep apnoea syndrome are possible. The
risk seems to be increased for elderly patients with pul-
monaryorcardiacconditions.Inthesecasesnasalpacks
should be avoided or used only temporarily under nightly
monitoring (i.e. pulse oximetry).
3.6 Tube dysfunction
Nasal packs may lead to temorary tube dysfunction with
negative middle ear pressure (as in the Toynbee maneu-
ver). According to most studies, breathing straws do not
alleviate this problem. However, pressure normalizes
rapidly when the nasal packs are removed.
3.7 Allergies
Allergies are an important factor and a careful inquiry
must be made prior to each procedure. The increase of
latex allergies has led to the development of latex free
GFT’s (Rhinotamp Latexfrei, Vostra, Aachen; Schaum-
stoffnasentamponademitlatexfreierBehautung,Spiggle
& Theis, Overath). The author recommends avoiding po-
tential problems by using only latex free materials, even
if they are more expensive. It is important to point out
that increased IgE antibodies against latex in RAST-tests
(about25%ofthegeneralpopulation),donotnecessarily
correspondtoclinicallyrelevantlatexallergies.Itisadvis-
able to question patients specifically about the use of
latex gloves or condoms. If there are no clear signs for
allergies,aRAST-testshouldbeavoided,sincetheresults
cause more confusion than help.
AnaphylacticallergicreactionstoCMChavebeenreported
[68], [69]. Muroi et al. found elevated CMC-specific IgE
antibodiesin9%of387screenedpatients[69].Onecase
of allergic reaction to Merocel has been reported as a
rare but possible reaction to polyvinyl chloride [70].
Allergic reactions must be considered for HT as well (i.e.
against thrombin).
3.8 Toxic shock syndrome
Toxic shock syndrome is a rare, multi system disease
characterized by high fever, diffuse erythema, vomitting,
diarrhoea and muscle pain at onset and can lead to
septicshock.Toxicshocksyndromeisararecomplication
following staphylococcal infection and is caused by toxic
shock syndrome toxin (TSST 1). Some streptococci can
cause TSS or severe inflammatory necrosis as well. Usu-
ally, TSS develops within 24 hours of nasal surgery and
is associated with the placement of nasal packs. On the
other hand, there have been reports of patients develop-
ing a delayed staphylococcal TSS (within days or up to 5
weeks after nasal sinus surgery or septoplasty) although
no nasal pack had been used [1]. So although nasal
stents or packs increase the risk for the development of
TSS, the exact role they play remains unclear. The devel-
opment of TSS is not limited to nasal pack or stent
placement! It can not be anticipated and can not be
avoided by antibiotics. It can develop after all endonasal
procedures.
Recognitionofthediseaseandimmediateandadequate
treatmentareimperative.Thisincludesimmediateremov-
al of nasal packs (if still in situ), immediate i.v. antibiotic
treatmentand possiblytransfer to an intensive careunit.
Second generation cephalosporins are ideal, targeting
both staphylococci and streptococci. The author recom-
mends application of the second dose after 4 hours to
optimize treatment in the critical early phase.
3.9 Nasal packs and antibiotics
A nasal pack is not per se an indication for antibiotic
treatment. The nasal pack ensures occlusive wound
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creaseingramnegativepathogenswithunpleasantodor)
but not to increased infection. In fact, occlusion leads to
a moist milieu which optimizes physiological defense
mechanisms and thus leads to less infections than open
wounds. There is no conclusive evidence that the use of
nasal packs leads to an increase in infections [71], [72].
The same applies to nasal packs with antibacterial addi-
tives. Routine application of antibiotics for patients with
nasal packs therefore does not seem necessary. The
author’sownextensiveexperienceconfirmsthatpatients
without an antibiotic showed no increase in infections.
Thetypicalunpleasantodorthatdevelopsafterprolonged
useofnasalpacksisduetocolonizationofgramnegative
bacteria[73]andshouldnotbemistakenforaninfectious
disease requiring treatment. Antibiotics seem advisable
in cases of acute bacterial infection (including purulent
intraoperative superinfection of chronic inflammation),
Diabetes or immune deficiencies, after performance of
durareconstructionoraftercompressionoftheEustachi-
an tube by packing in the nasopharynx. According to the
author’s knowledge, there are no high quality studies
available on this topic.
If swelling in the nose or mid face occur, or the nose be-
comes tender to touch while a nasal pack is placed, the
author recomends immediate removal and application
of an antibiotic that is effective for both staphylococci
and streptococci, i.e. a secon generation cephalosporin.
As soon as the inflammatory signs have regressed, the
antibiotic treatment can be discontinued. According to
the author’s experience, continued oral antibiotic treat-
ment is unnecessary.
3.10 Paraffin granuloma and
spherulocytosis
Paraffin granulomas or paraffinomas develop if the peri-
orbit has been damaged (signaled by a „black eye“) and
paraffin ointments are used, for example for nasal pack
placement [74]. Paraffinomas have also been described
following rhinoplasty when paraffin drenched gauze is
used. Paraffin is a common ingredient for ointments but
not gels. Paraffin ointmentsare not degradableand lead
toforeignbodyreactions.Ifparaffinisinjectedintotissue,
typical parrafinomas or lipo granulomas develop over a
time period of weeks or years.
Paraffingranulomspresentasslowgrowingsolidmasses.
Histologically they are characterized by giant cell foreign
body granulomas and numerous vacuoles of different
sizes. These develop when the tissue is deparaffinized.
Surrounding the vacuoles are signs of tissue reaction.
Because paraffinomas are diffuse, complete removal is
difficult.Still,surgicalremovalistheonlyviabletreatment.
Since small peri orbital lesions may remain undetected
(swelling of the cheeks may develop following diffuse
bleeding, dehiscence along the anterior ethmoid artery,
or postoperative pressure increases), it is imperative to
avoid paraffin based ointments or creams during nasal
sinus surgery.
Spherulocytosis or myospherulosis is a foreign body re-
action occuring after the use of antibiotic ointments in
wounds or on muscles [75]. Dilateted cystic spaces of
varying size surrounded by histiocytes and multi nuclear
giant cells are observed in histological examination. The
foreign body reaction has been reported for varying anti-
bioticointmentsandseemstobecausedbytheemulsion
of aliphatic materials in blood. Spherulocytosis and par-
affin granulomas seem closely related.
3.11 Nasal packs as foreign bodies
Nasalpacksthatareforgottenandleftinthenoseduring
or after surgical procedures can lead to infalmmatory
complications.Gotwaldetal.reportedaboutgauzestrips
left in the ethmoid [76], leading to the recommendation
touseonlystripswithx-raymarkings[77].Intheauthor’s
opinion it is important to only use packs that can be
identified from outside the nose during or after surgery.
This is especially recommended for thin gauze strips.
Neuro swabs with threads are to be preferred for hemo-
stasis during surgery. If materials (stents, struts etc...)
are to be left in the nasal space, this must be carefully
documented and discussed with the patient. The foreign
bodiesmustbeplacedcorrectlyandfirmlysecured.Follow
up must be guaranteed and removal planned.
4 Requirements for new products
and training
Theauthorurgentlyrecommendsthatendonasalapplica-
tion of substances without solid evidence for effectivity
or benefit be avoided. This is especially the case for
substances which have proven negative effects, even if
„experience“ might indicate otherwise.
InagreementwithOrlandi2007,theauthorrecommends
that nasal pack materials be thoroughly tested prospec-
tively before being used in clinical practice [39]. New
materials should not be tested against those already
known for their poor performance, making them appear
promising. Follow up testing and clinical practice often
revealnotonlylackingsuperioritybutevennewrisks(see
Merogel, FloSeal, chapter 2.2.6. and 3.3.)
Requirements for nasal packs
Thefollowingcharacteristicsshouldberequiredfornasal
packs and stents in endonasal surgery (1):
• non toxic
• non allergenic
• inert (no foreign body reactions)
• non dislocating
• easily placed
• easily removed
• painless (patient comfort)
• adaptabletoindividualanatomicvariations(hemostas-
is, wound healing)
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• ensure breathing
• preserve smell
Characteristics required for hemostatic packs include:
• achieve hemostasis of arterial, venous or capillary
bleeding within 2 minutes
• ready for use without tedious preparation
• easy to apply
• lack tissue side effects
• safe (no risk for the transmission of diseases)
• low-cost
• light and durable, stable at room temperature and
keep for at least 2 years, even under extreme temper-
atures (important for military applications!)
Inthefutureaspectssuchasinteractionbetweenforeign
materials, micro organisms and body tissues will need to
be considered. Incorporation of granulation tissue, for
example, is determined not only by the size of pores in
theforeignmaterialused.Thecellsinvolvedalsodepend
on adhesion, so the absorptive, adhesive or repellent
qualities of the material also play a major role. Nasal
packs should also allow the release of medications to
influence wound healing (i.e. growth factors, cytokines),
even if this has not yet been successful (cortisol in hya-
luronic acid (Merogel), IGF-1 in HA [78], [79] and cortisol
in GMC [80]).
Training
In Great Britain training the placement of nasal packs on
models has been repeatedly recommmended [81], [82],
[83](LaerdalAirwayManagementtrainer,LaerdalMedical
Libited UK, Orpington, Kent, http://www.laerdal.com/
de/). The author supports this recommendation, which
is common for many surgical procedures. Considering
how often poorly placed nasal packs lead to „unstop-
pable“ nose bleeding, training seems more than called
for.
AstudyinGreatBritainshowedtheimportanceofcorrect
placement of nasal packs for management of epistaxis.
WhenplacedbyanENT,nasalpacksweremoreeffective
(i.e. avoiding further treatment, like cautery) than when
placed by an emergency physician [84].
5 Nasal packs – summary of
current clinical assessment
There is no single nasal pack that is suited to all indica-
tions. High quality patient care can only be provided if
ENT’s have an array of nasal packs at their disposal for
different indications.
The prime factor in choice of packing for sinus surgery is
the type of procedure performed. Atraumatic, and thus
intheauthor’sopinion,predominatelyendoscopicsurgery
according to pathophysiological criteria, allows for inno-
vations in nasal packing.
• This type of surgery often does not require nasal
packingatall,considerablyincreasingpatientcomfort.
However,occlusion,andthusafavorablemoistmilieu,
is not achieved either.
• IfFKT’sareappliedaftersurgerytoachievehemostas-
is, they should be atraumatic: GFT, coated PVA-NT,
Netcell with synthetic coating, possible Rapid Rhino.
Depending on individual parameters, the nasal pack
canberemovedthesamedayorafteroneortwodays.
Longer placement does not seem warranted.
• Ifocclusiontostimulatewoundhealingisdesired,and
noothersideeffectsbesidesimpairednasalbreathing
aretobeexpected,thenasalvestibulumcanbeclosed
using soft adhesive tape. This is simple, effective and
economical and can be applied to one or both sides
(Figure2).Thiscreatesamoistendonasalmilieuwhich
prevents dryness and crusting.
Figure 2: Occlusion of the nose for better intranasal wound
healing (moist environment)
Occlusion can, of course, also be achieved by more
elaborate products. However, alternative FKT’s may lead
to accumulation of blood and fibrin in the ethmoid oder
frontalsinusdrains,whichcanleadtoscarring.Occlusion
is maintained, until wound healing has progressed suffi-
ciently. After „normal“ pan-sinus surgery one week is
usually sufficient. In tumor-surgery the author usually
chooseslongerintervals.Duringocclusiontheapplication
of ointments, nasal irrigation or cleaning is not usually
required. Although secretion is increased, infections are
not more frequent since physiological defense mecha-
nismsaboundinthismilieu.Theonlydisadvantageisthe
complete obstruction of nasal breathing.
• For management of posterior epistaxis that is not en-
doscopically controlled, an atraumatic variant of a 10
cm PVA-NT (i.e. Netcell) or a BK is recommended.
• Because of their known side effects, HT (especially
FloSeal,esterifiedHA)cannotberecommended.Time
will tell if cross-linked materials or CMC-gel produce
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effectivity also support this assessment. Nasal air
passage may be preserved in some cases, if NT’s are
placeddirectlyintotheethmoid(GFT,coatedPVA,slim
Rapid Rhino).
Economicfactors,includingcost-effectivenssratio,must
also be considered when using nasal packs. The primary
goal of the physician is to increase patient comfort and
safety. Even if new developments are more costly, they
should be employed for the benefit of our patients. Poli-
tics,administrationandcontrollingshouldnotdetermine
our professional choices.
6 Stents/Struts
Stents or struts (synonymous terms in the author’s opin-
ion) are used in sinus surgery to prevent scarring and
constriction of newly formed sinus openings. At present
only stenting of the frontal sinus is indicated.
6.1 Maxillary sinus stenting
Maxillary sinus stents for the middle meatus have been
described [1], [85] and have led to good results, but are
not necessary. The maxiallary sinus is easily and atrau-
matically reached using endoscopic techniques. In revi-
sion cases with a narrow middle meatus, an alternative
opening can be made under the inferior turbinate. In
cases of revision surgery, for example after Caldwell-Luc
procedures, the inferior turbinate can be temporarily di-
vided to provide ample maneuvering space. Stents can
be placed [86], but seem avoidable if good surgical
technique is employed.
6.2 Middle turbinate stenting
To prevent adhesions between the middle turbinate and
the lateral nasal wall, which would otherwise obstruct
passage to the ethmoid, different products have been
used. The only currently viable product is a “u”-shaped
coat for the middle turbinate, a poly urethane glove,
“Boomerang Turbinate Glove” (Medtronic).
Aside from atraumatic surgical techniques, leaving por-
tionsoftheethmoidbullatopreventlateraldisplacement
of the middle turbinate, transseptal suture techniques
and bolgerisation have proven effective.
6.3 Frontal sinus stenting (SHPH)
Constriction of sinus ostia appears to be the result of
blood and fibrin deposits, membrane damage, contact
betweenswollensurfacesandcircularstricture.Denuded
bonesurfacescanalsoshow granulationtissuedevelop-
ment and even neoosteogenesis. A SHPH is therefore
designed to act as a splint to guide ephithelial regenera-
tion, prevent filling of spaces with blood and fibrin and
reduce granulation. Subepithelial scars consolidate as
long while the stent is in place. Therefore effective
stenting seems to require placement for several months,
until wound healing is completed [1], [4], [5].
Indications for endonasal surgical approaches can be
broadened if combined with stent placement. Especially
in cases of a narrow ethmoid space, extensive wound
surfaces or scar revision, stenting represents an alterna-
tivetoTypeIIIdrainageorobliteration.Atypicalindication
is revision after Jansen-Ritter procedures with collapsing
of lateral frontalsinus drain and developmentof a muco-
cele. Local follow up treatment with instruments in the
frontal space is not required.
Atpresent,anumberoffrontalsinusstentsareavailable:
• Rains frontal sinus stent (Gyrus GmbH): the stent is
self retaining by a small expandable bulb. This is de-
signed to prevent dislocation and aspiration. The au-
thor has had many years of experience with this stent.
• Parrel frontal sinsus T-stent (Medtronic – Xomed
GmbH): achieves self retainment by T-schaped diver-
gent ends.
• Jacobs frontal sinus cannula (Hood Laboratories,
Pembroke, MA, USA): uses a cross-shaped anchor.
• Freemann frontal sinus stent (Fahl Medizintechnik,
Kerpen): biflanged for retention.
• InGermanysiliconeorpolythylenetubes(Weber)were
usedover10yearsago.Thesecannotberecommend-
ed any more, since commercially available stents are
made of softer materials and do not require sutures
to secure them.
• The author has also given up using U-shaped or H-
shapedsiliconetubeswhichwereplacedtransseptally
after Type-III drainage.
• First results with frontal sinus stents drenched in
dexamethasone [87] seem promising, but must be
confirmed in larger studies.The use of cytostatictaxol
(paclitacel), which also shows anti-angiogenetic and
anti-proliferative qualities in animals showed results
comparable to uncoated stents 4 weeks after place-
ment (N=4) [88]. Currentstudiesare investigatingthe
use of doxycyclin (Bachert, personal communication
2008), which led to improved results (publication in
process).
The opinion that firm frontal sinus stents are inferior to
soft materials is based on the results of Neel et al. in
1976, who investigated the influence of stents on the
frontalsinusdrainin8dogs[89].2dogsreceivedsurgery
apart from the frontal sinus, in 2 cases the frontal sinus
ostium was drilled to a size of 1.5 cm diameter without
stentplacement,intheremaining4casesonesoft(rolled
silicone membrane) and one hard stent (silicone tube)
wasplaced.After2monthsthestentswereremovedand
after another 4 months histological investigation took
place. For hard stents 2 of 4 drains werde completely
obliterated, 2 showed ostia of 1–2 mm diameter. Of the
4 treated with soft stents, 3 showed ostia 4 mm in dia-
meter and one 2 mm in diameter. It is debatable, how-
ever, if these results haven conclusively demonstrated
that hard stents lead to inferior results than soft stents.
The poor results may also have been the result of
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necrosis and scarring rather than wound healing. Still
criticism of hard stents seems plausible. Flexible SHPH
have the advantage of being adaptable to individual
anatomicfeatures.Italsoseemsplausiblethatexcessive
pressure has a negative effect on wound healing.
Common problems for all silicone stents include:
• edema caused by the foreign body. Edema usually re-
gresses within 4 weeks;
• crusting at the nasal end and irritation of the lateral
nose wall and septum;
• persisting nasal secretion;
• retention of secretion in the frontal sinus with uncom-
fortable pressure and even superinfection if drainage
past the SHPH is not sufficient.
Removal of the stent (i.e. the Rains SHPH) is also often
associated with a short but intense pain and even
bleeding, since the stent is not soft enough to be com-
pletely atraumatic.
The results of surgery of the frontal sinus with the use of
stents are encouraging. Still, advantages and disadvan-
tagesmustbeweighedineachindividualcaseandshould
be discussed with the patient at length. It is important to
allowforplacementoversufficientlylongintervals.Wound
healingshouldpassstage3(reorganisationandscarring).
Thismeansaperiodofabout6monthsseemsadvisable,
as recommended by Yamasoba and Schaller [90], [91].
In the author’s own prospective study [4], placement of
stents for 6 months after Type II drainage surgery led to
significantly reduced stenosis of the neo-ostium. After
12–16 months follow up, the ostium was open in 80%
of the cases versus 33% treated only endoscopically.
Bamhiran et al. placed individualized thin silicone mem-
branes that completely covered the drain space for 8
weeks after Type III surgery. After an average of 22
months follow up (6–75 months), stenosis was similar
for both stent and non-stented cases: 60% versus 61.5%
open, 32% versus 35.9% reduced and 8% versus 2.6%
obliterated. Reduction of the neo-ostium occured within
the first 10 months of follow-up. Rains removes stents
whentheethmoidalsurfaceofthedrainshowsepithelial
regeneration and there is no purulent secretion or
polypoidmucosa[92].Thisoccursafteranaverageof35
(6–39) days (102 patients). Open frontal ostia were re-
ported in 67 patients with a rate of 94% after 8–46
months. Linn and Witerick analyzed 21 frontal sinus
stents in 11 patients after placement of stents for over
3 months [93]. At the time 10 stents were still in place,
the others had been removed after an average of 16.3
months. Spontaneous dislocation occured in 14% after
an average of 8.8 months. Irreversible obstruction oc-
cured in 5% of the cases.
In summary then, SHPH can be helfpul in certain cases.
Theymustremainplaced,however,forasufficientlength
of time. At present none of the available products are
ideal.Themainproblemistheinadequateformsavailable
(round with a diameter of 4–6 mm), which do not always
coincidewithindividualfrontalsinusopenings.Theauthor
currently prefers optimizing surgical technique with spe-
cial instruments for the frontal sinus [94], [95] and uses
stentslessoftenthatanumberofyearsago.WennSHPH
are used, one should:
• usemultipleSHPHtoavoidaroundformandincrease
the diameter in at least one plain;
• avoid excessive pressure on wound surfaces which
canleadtonecrosisandimpairedhealingbyemploying
individualized silicone membranes;
• leave stents in situ for 6 months or until healing is
confirmed by endoscopy.
Abbreviations
BK = Ballonkatheter (balloon catheter)
BWGS = Baumwollgazestreifen (cotton gauze strips)
ENT = Expandierbare Nasentamponade(n) (expandable
nasal pack)
FESS = funktionelle endoskopische NNH-OP (functional
endoscopic sinsus surgery)
FKT = Formkörpertamponade (formed nasal packs)
HA = Hyaluronsäure (hyuloronic acid)
HT = Hämostatische / Resorbierbare / Biologisch ab-
baubareTamponaden(hemostatic,resorbable,biodegrad-
able packs)
MPH = mikroporöse Polysaccharidhemisphären (micro
pore poly sacharide hemispheres)
NNH = Nasennebenhöhlen (nasal sinuses)
NT = Nasentamponade(n) (nasal pack)
OSAS = Obstruktives Schlafapnoesyndrom (obstructive
sleep apnoea syndrome)
PU = Polyurethan (poly urethane)
PVA-NT = Polyvinylacetal-Nasentamponaden (poly vinyl
acetal nasal pack)
SHD = Stirnhöhlendrainage (frontal sinus drain)
SHPH = Stirnhöhlenplatzhalter (frontal sinus stent)
TSS=ToxischesSchockSyndrom(toxicshocksyndrome)
VAS = Visuelle Anologskala (visual analogue scale)
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